Protective effect of propranolol on the hypertrophied heart during cardiopulmonary bypass.
D000328:Adult; D000368:Aged; D001022:Aortic Valve Insufficiency / Q000601:surgery; D001024:Aortic Valve Stenosis / Q000601:surgery; D001706:Biopsy; D002118:Calcium / Q000097:blood; D006332:Cardiomegaly; D005112:Extracorporeal Circulation; D005260:Female; D006324:Heart Arrest, Induced / Q000009:adverse effects*; D006325:Heart Atria / Q000032:analysis; D006350:Heart Valve Prosthesis; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D007773:Lactates / Q000097:blood; D008297:Male; D008875:Middle Aged; D010758:Phosphorus / Q000097:blood; D011188:Potassium / Q000097:blood; D011433:Propranolol / Q000032:analysis / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D011773:Pyruvates / Q000097:blood; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000209:etiology / Q000517:prevention & control*
D007773:Lactates; D011773:Pyruvates; D010758:Phosphorus; D011433:Propranolol; D011188:Potassium; D002118:Calcium